Centre Hospitalier de Chaumont in France Implements State-of-the-Art Remote Monitoring System to Advance Patient Safety

PARIS and IRVINE, Calif., Sept. 12, 2011 /PRNewswire/ -- Patients admitted to Centre Hospitalier (CH) de Chaumont in France can feel safer thanks to a new technological guardian angel.  Today, in addition to hospital staff, patients at Chaumont are being safeguarded by Masimo Patient SafetyNet™—a new, advanced remote monitoring and wireless clinician notification system designed to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events—one of today's most common medical errors.(1)

(Photo:  http://photos.prnewswire.com/prnh/20110912/LA64995)

"Patients need to know that there are systems dedicated specifically to safeguarding their health and safety in place at some hospitals, and we're on the forefront of this effort," stated Vartan Iknoyan, Biomedical Chief Engineer at Centre Hospitalier de Chaumont. "As a Patient SafetyNet™ hospital, Chaumont now utilizes this state-of-the-art remote noninvasive monitoring system to help keep our patients from deteriorating to the point of critical danger—helping us to achieve better outcomes, recoveries, and patient satisfaction in the process."

Developed by Masimo (NASDAQ: MASI), Patient SafetyNet™ helps keep patients safer by noninvasively, continuously measuring and tracking the underlying physiological condition of up to 80 patients on four floors to detect real-time changes and abnormalities that signal declining health status.  The moment a patient's condition deteriorates, the system automatically sends wireless alerts directly to the pager or smartphone of assigned clinicians—prompting an immediate, potentially lifesaving response at the patient's bedside.  Patient SafetyNet™ has been clinically-proven to significantly decrease traumatic critical events by 65% and costly ICU transfers by 48% to improve patient outcomes and reduce costs.(1)

According to Dr. Bernard Simon, Head of the Department of Pneumology and Oncology at Centre Hospitalier de Chaumont, Patient SafetyNet has made a big impact on care.  "First thing we noticed was a significant reduction in false alarms because the technology is more advanced and accurate.  Not having to chase down false alarms has allowed our clinicians to be more efficient and focus more attention on the care and treatment of patients.  The system's ability to monitor and detect real-time changes in a patient's condition enable us to anticipate serious problems and intervene earlier, which allows us to reduce critical events, transfers to the ICU, and length of stays by improving clinical decision-making so that our patients can get better sooner."

The Patient SafetyNet™ system features a noninvasive patient sensor [finger or acoustic respiration neck sensor] and bedside patient monitor [Masimo Rad-87® or Radical-7® Pulse CO-Oximeter™] that continuously captures vital physiological measurements—including: total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), acoustic respiration rate (RRa™), oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR)—and wirelessly transmits them to the central monitoring station, which displays the real-time clinical status of all connected patients and instantly routes alarms to the pager or smartphone of assigned clinicians. (See Figure 1 for the Complete System)

About Centre Hospitalier de Chaumont

Si son origine remonte probablement au debut de ce millenaire, l'Hotel-Dieu, lieu de charite au cœur de la cite qui jouxtait l'eglise Saint-Michel situee sur l'actuelle Place des Halles, ferma ses portes en 1748 pour inadaptation et insalubrite.  Des dons de toute nature permirent la mise en service en 1767 de l'hopital de Chaumont, construit de part et d'autre de la chapelle.  Sous la conduite materielle et spirituelle des religieuses de la Confrerie des Filles de la Charite, l'etablissement s'est agrandi au cours du 19eme siecle – pavillon VILLEMIN, detruit et remplace par une partie du nouveau plateau technique abritant le laboratoire, l'accueil des urgences et le SAMU/SMUR ; puis juste avant la premiere guerre mondiale – les pavillons MAILLOT et LARREY, reserves a l'hospitalisation des militaires.

About Masimo

Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems.  In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events.  More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion.  In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry™ technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI).  In 2008, Masimo introduced Patient SafetyNet™, a remote monitoring and wireless clinician notification system designed to help hospitals avoid preventable deaths and injuries associated with failure to rescue events.  In 2009, Masimo introduced rainbow Acoustic Monitoring™, the first-ever noninvasive and continuous monitoring of acoustic respiration rate (RRa™).  Masimo's rainbow SET technology platform offers a breakthrough in patient safety by helping clinicians detect life-threatening conditions and helping guide treatment options.  In 2010, Masimo acquired SEDLine®, a pioneer in the development of innovative brain function monitoring technology and devices.  Masimo SET and Masimo rainbow SET technologies can be also found in over 100 multiparameter patient monitors from over 50 medical device manufacturers around the world.  Founded in 1989, Masimo has the mission of "Improving Patient Outcome and Reducing Cost of Care ... by Taking Noninvasive Monitoring to New Sites and Applications®." Additional information about Masimo and its products may be found at www.masimo.com.

Masimo Media Contact:
Dana Banks, Director of Corporate Communications
+ (949) 297-7348 / [email protected]

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5, Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or registered trademarks of Masimo Corporation.

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to:  risks related to our belief that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events, risks related to our assumptions of the repeatability of clinical results obtained, and risks related to the system's ability to significantly decrease traumatic critical events and costly ICU transfers to help improve patient outcomes and reduce costs, as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

(1)  Taenzer AH, Pyke JB, McGrath SP, Blike GT. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study" Anesthesiology; February 2010; Vol 112, Issue 2, pp 282-287.

SOURCE Masimo Corporation